Cannabigerorcinic Acid
(Synonyms: Cannabigerorcinolic Acid, Cannabiorcogerolic Acid, CBGOA) 目录号 : GC47030An Analytical Reference Standard
Cas No.:69734-83-4
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cannabigerorcinic acid is an analytical reference standard that is structurally similar to known phytocannabinoids. Cannabigerorcinic acid is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
N/A
Cas No. | 69734-83-4 | SDF | |
别名 | Cannabigerorcinolic Acid, Cannabiorcogerolic Acid, CBGOA | ||
Canonical SMILES | OC1=C(C/C=C(C)/CC/C=C(C)/C)C(O)=C(C(O)=O)C(C)=C1 | ||
分子式 | C18H24O4 | 分子量 | 304.4 |
溶解度 | DMF: 25 mg/ml,DMSO: 25 mg/ml,Ethanol: 30 mg/ml,Ethanol:PBS (pH 7.2)(1:2): 0.3 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.2852 mL | 16.4258 mL | 32.8515 mL |
5 mM | 0.657 mL | 3.2852 mL | 6.5703 mL |
10 mM | 0.3285 mL | 1.6426 mL | 3.2852 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Terpenoids and Meroterpenoids from Cultures of Two Grass-Associated Species of Amylosporus (Basidiomycota)
J Nat Prod 2022 Apr 22;85(4):846-856.PMID:35175766DOI:10.1021/acs.jnatprod.1c00975
An investigation of the chemical components of the fermentation extract of two cultures of Amylosporus cf. graminicola and Amylosporus cf. campbelii from Cuba and Zimbabwe, respectively, led to the isolation of seven previously undescribed secondary metabolites for which we proposed the trivial names amylosporanes A-G (1-7) along with the known compounds orsellinic acid (11), colletorin D acid (12), colletorin B (13), colletochlorin B (14), and the β-lactam cyclo-(S-Pro-R-Leu) (15). Three additional compounds (8-10) previously unknown from a fungal source were also characterized for the first time, and two of them were assigned the trivial names amylosporanes H-I (8-9) while the other was identified as Cannabigerorcinic Acid (10). The structures of the isolated compounds were determined based on their high-resolution electrospray ionization mass spectrometry (HR-ESIMS) spectra and an extensive analysis of their 1D and 2D NMR spectroscopic data. Based on literature searches, we hypothesized that a majority of the isolated metabolites have orsellinic acid (11) as a biosynthetic precursor following a combined route of mevalonate-associated and orsellinic acid-associated pathways. Colletochlorin B (14), the only compound possessing chlorine in its structure, exhibited significant activity against Bacillus subtilis (minimum inhibitory concentration, 2 μg/mL), stronger than that of oxytetracycline, and significant cytotoxicity against A431 cells with an IC50 value of 4.6 μM.